CliffBio
small molecule

DIASONE SODIUM

SULFOXONE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIASONE SODIUM
Active ingredientSULFOXONE SODIUM
Strength165MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DIASONE SODIUM patent cliff — loss of exclusivity — | CliffBio